It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2021.
2021 | New Delhi, Delhi, India | ActiveRivexia Pharmaceuticals Private Limited, a active private limited company, was established on 30 September 2021 in New Delhi, Delhi, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290DL2021PTC387532. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Anuradha Kumari (Director), Amrit Raj (Additional Director). Past directors included Rishi Roushan Kant. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Ashok Kumar Sehgal ,F 34/8 Okhla Industrial Area , Phase Ii, New Delhi, Delhi, 110020.
U24290DL2021PTC387532
387532
30 September 2021
₹1.00 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rivexia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anuradha Kumari | Director | 30 Sep 2021 | Current |
| Amrit Raj | Additional Director | 01 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rivexia Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Rivexia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rivexia Pharmaceuticals has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rivexia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rivexia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rivexia Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was completed.
Progress on Amrit Raj was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2024 & has been associated with this company since 1 year 4 months . was documented.
Rivexia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Anuradha Kumari was appointed as a Director was appointed as a Director on 30 Sep 2021 & has been associated with this company since 4 years 2 months . was completed.
Rivexia Pharmaceuticals Private Limited was registered on 30 Sep 2021 with Roc Delhi & aged 4 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Rivexia Pharmaceuticals Private Limited is U24290DL2021PTC387532.
Rivexia Pharmaceuticals Private Limited is headquartered at C/O Ashok Kumar Sehgal ,F 34/8 Okhla Industrial Area , Phase Ii, New Delhi, Delhi, 110020.
Rivexia Pharmaceuticals Private Limited was incorporated on 30 September 2021.
The current directors of Rivexia Pharmaceuticals Private Limited are
The primary industry of Rivexia Pharmaceuticals Private Limited is Chemicals.
Rivexia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rivexia Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX